Abstract
We have identified the physical interaction between the Breast Cancer susceptibility gene product BRCA1 and the Hereditary Non-Polyposis Colorectal Cancer (HNPCC) and DNA mismatch repair (MMR) gene product hMSH2, both in vitro and in vivo. The BRCA1-hMSH2 association involved several well-defined regions of both proteins which include the adenosine nucleotide binding domain of hMSH2. Moreover, the interaction of BRCA1 with purified hMSH2-hMSH6 appears to be modulated by adenosine nucleotide much like G protein downstream interaction/signaling is modulated by guanosine nucleotide. BARD1, another BRCA1-interacting protein, was also found to interact with hMSH2. In addition, BRCA1 was found to associate with both hMSH3 and hMSH6, the heterodimeric partners of hMSH2. These observations implicate BRCA1/BARD1 as downstream effectors of the adenosine nucleotide-activated hMSH2-hMSH6 signaling complex, and suggest a global role for BRCA1 in DNA damage processing. The functional interaction between BRCA1 and hMSH2 may provide a partial explanation for the background of gynecological and colorectal cancer in both HNPCC and BRCA1 kindreds, respectively.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
Abbreviations
- MMR:
-
mismatch repair
- TCR:
-
transcription-coupled DNA damage repair
References
Acharya S, Wilson T, Gradia S, Kane MF, Guerrette S, Marsischky GT, Kolodner R, Fishel R . 1996 Proc. Natl. Acad. Sci. USA 93: 13629–13634
Amundson SA, Zhan Q, Penn LZ, Fornace Jr AJ . 1998 Oncogene 17: 2149–2154
Anderson SF, Schlegel BP, Nakajima T, Wolpin ES, Parvin JD . 1998 Nat. Genet. 19: 254–256
Bush A, Mateyak M, Dugan K, Obaya A, Adachi S, Sedivy J, Cole M . 1998 Genes. Dev. 12: 3797–3802
Chai YL, Cui J, Shao N, Shyam E, Reddy P, Rao VN . 1999 Oncogene 18: 263–268
Chapman MS, Verma IM . 1996 Nature 382: 678–679
Chen Y, Farmer AA, Chen CF, Jones DC, Chen PL, Lee WH . 1996 Cancer Res. 56: 3168–3172
Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L, Ganguly A, Rebbeck T, Weber BL . 1997 N. Engl. J. Med. 336: 1409–1415
de Boer J, Donker I, de Wit J, Hoeijmakers JH, Weeda G . 1998 Cancer Res. 58: 89–94
Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R, Ruschoff J . 1997 Cancer Res. 57: 4749–4756
Drummond JT, Anthoney A, Brown R, Modrich P . 1996 J. Biol. Chem. 271: 19645–19648
Drummond JT, Li GM, Longley MJ, Modrich P . 1995 Science 268: 1909–1912
Easton DF, Ford D, Bishop DT . 1995 Am. J. Hum. Genet. 56: 265–271
Fishel R . 1998 Genes. Dev. 12: 2096–2101
Fishel R . 1999 Nat. Med. 5: 1239–1241
Fishel R, Ewel A, Lescoe MK . 1994 Cancer Res. 54: 5539–5542
Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R . 1993 Cell 75: 1027–1038
Gowen LC, Avrutskaya AV, Latour AM, Koller BH, Leadon SA . 1998 Science 281: 1009–1012
Gradia S, Acharya S, Fishel R . 1997 Cell 91: 995–1005
Gradia S, Acharya S, Fishel R . 2000 J. Biol. Chem. 275: 3922–3930
Gradia S, Subramanian D, Wilson T, Acharya S, Makhov A, Griffith J, Fishel R . 1999 Mol. Cell 3: 255–261
Guerrette S, Acharya S, Fishel R . 1999 J. Biol. Chem. 274: 6336–6341
Guerrette S, Wilson T, Gradia S, Fishel R . 1998 Mol. Cell. Biol. 18: 6616–6623
Hanawalt PC . 1994 Science 266: 1957–1958
Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Maheswaran S, Oliner JD, Haber DA . 1999 Cell 97: 575–586
Jensen RA, Thompson ME, Jetton TL, Szabo CI, van der Meer R, Helou B, Tronick SR, Page DL, King MC, Holt JT . 1996 Nat. Genet. 12: 303–308
Li S, Chen PL, Subramanian T, Chinnadurai G, Tomlinson G, Osborne CK, Sharp ZD, Lee WH . 1999 J. Biol. Chem. 274: 11334–11338
Lynch HT, Smyrk T, Lynch J . 1997 Cancer Genet. Cytogenet. 93: 84–99
Maldonado E, Shiekhattar R, Sheldon M, Cho H, Drapkin R, Rickert P, Lees E, Anderson CW, Linn S, Reinberg D . 1996 Nature 381: 86–89
Marhin WW, Chen S, Facchini LM, Fornace Jr. AJ, Penn LZ . 1997 Oncogene 14: 2825–2834
Mello JA, Acharya S, Fishel R, Essigmann JM . 1996 Chem. Biol. 3: 579–589
Mellon I, Rajpal DK, Koi M, Boland CR, Champe GN . 1996 Science 272: 557–560
Monteiro AN, August A, Hanafusa H . 1996 Proc. Natl. Acad. Sci. USA 93: 13595–13599
Neuhausen SL, Marshall CJ . 1994 Cancer Res. 54: 6069–6072
Peltomaki P, Vasen HF . 1997 Gastroenterology 113: 1146–1158
Ruffner H, Jiang W, Craig AG, Hunter T, Verma IM . 1999 Mol. Cell. Biol. 19: 4843–4854
Ruffner H, Verma IM . 1997 Proc. Natl. Acad. Sci. USA 94: 7138–7143
Sancar A . 1994 Science 266: 1954–1956
Schmutte C, Marinescu RC, Sadoff MM, Guerrette S, Overhauser J, Fishel R . 1998 Cancer Res. 58: 4537–4542
Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, Livingston DM, Parvin JD . 1997a Proc. Natl. Acad. Sci. USA 94: 5605–5610
Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston DM . 1997b Cell 90: 425–435
Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM . 1997c Cell 88: 265–275
Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Wu GS, Licht JD, Weber BL, El-Deiry WS . 1997 Nature 389: 187–190
Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA . 1997 N. Engl. J. Med. 336: 1401–1408
Wang Q, Zhang H, Kajino K, Greene MI . 1998 Oncogene 17: 1939–1948
Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J . 2000 Genes Dev. 14: 927–939
Wilson CA, Payton MN, Pekar SK, Zhang K, Pacifici RE, Gudas JL, Thukral S, Calzone FJ, Reese DM, Slamon DI . 1996 Nat. Genet. 13: 264–265
Wilson T, Guerrette S, Fishel R . 1999 J. Biol. Chem. 274: 21659–21664
Wilson TM, Ewel A, Duguid JR, Eble JN, Lescoe MK, Fishel R, Kelley MR . 1995 Cancer Res. 55: 5146–5150
Wong AK, Ormonde PA, Pero R, Chen Y, Lian L, Salada G, Berry S, Lawrence Q, Dayananth P, Ha P, Tavtigian SV, Teng DH, Bartel PL . 1998 Oncogene 17: 2279–2285
Yu X, Wu LC, Bowcock AM, Aronheim A, Baer R . 1998 J. Biol. Chem. 273: 25388–25392
Zhang H, Richards B, Wilson T, Lloyd M, Cranston A, Thorburn A, Fishel R, Meuth M . 1999 Cancer Res. 59: 3021–3027
Zhang H, Somasundaram K, Peng Y, Tian H, Bi D, Weber BL, El-Deiry WS . 1998 Oncogene 16: 1713–1721
Zhang HT, Zhang X, Zhao HZ, Kajino Y, Weber BL, Davis JG, Wang Q, O'Rourke DM, Zhang HB, Kajino K, Greene MI . 1997 Oncogene 14: 2863–2869
Zhong Q, Chen CF, Li S, Chen Y, Wang CC, Xiao J, Chen PL, Sharp ZD, Lee WH . 1999 Science 285: 747–750
Acknowledgements
We thank Dr Barbara Weber for pCR3-BRCA1, Drs Gideon Dreyfuss, Qing Liu and Lili Wan for the support on the yeast two-hybrid system, Hansjuerg Alder and the members of the Sidney Kimmel Nucleic Acid Facility for nucleotide synthesis and sequencing, Christoph Schmutte for help in preparing the Figures for this manuscript, Samir Acharya, Scott Gradia, and Greg Tombline for helpful discussions. This work was supported by grants from the Abramson Family Cancer Research Institute, CaPCURE, NIH, and the U.S. Army (MI Greene) and NIH/NCI (R Fishel).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, Q., Zhang, H., Guerrette, S. et al. Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1. Oncogene 20, 4640–4649 (2001). https://doi.org/10.1038/sj.onc.1204625
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.onc.1204625


